Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,074 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Capillary-driven horseshoe vortex forming around a micro-pillar.
Ozawa K, Nakamura H, Shimamura K, Dietze GF, Yoshikawa HN, Zoueshtiagh F, Kurose K, Mu L, Ueno I. Ozawa K, et al. J Colloid Interface Sci. 2023 Jul 15;642:227-234. doi: 10.1016/j.jcis.2023.03.039. Epub 2023 Mar 15. J Colloid Interface Sci. 2023. PMID: 37004257
[Double cortex syndrome].
Yoshikawa H, Kudo Y, Ozawa K. Yoshikawa H, et al. Among authors: ozawa k. No To Shinkei. 1999 May;51(5):448-9. No To Shinkei. 1999. PMID: 10396753 Japanese. No abstract available.
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.
Murakami M, Miyata Y, Nakashima K, Abe M, Nishimura J, Wada M, Iino K, Akechi T, Iihara H, Imamura CK, Okuyama A, Ozawa K, Kim YI, Sasaki H, Satomi E, Takeda M, Tanaka R, Nakamura N, Noda M, Hayashi K, Higashi T, Boku N, Matsumoto K, Matsumoto Y, Okita K, Yamamoto N, Aogi K, Nakajima TE. Murakami M, et al. Among authors: ozawa k. Int J Clin Oncol. 2024 Nov 21. doi: 10.1007/s10147-024-02663-4. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39570460
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
Nakashima K, Harashima S, Kaneko R, Tanaka R, Abe M, Wada M, Iino K, Akechi T, Iihara H, Imamura CK, Okuyama A, Ozawa K, Kim YI, Satomi E, Takeda M, Nakajima TE, Nakamura N, Nishimura J, Noda M, Hayashi K, Higashi T, Boku N, Matsumoto K, Matsumoto Y, Okita K, Yamamoto N, Aogi K, Sasaki H. Nakashima K, et al. Among authors: ozawa k. Int J Clin Oncol. 2024 Nov 12. doi: 10.1007/s10147-024-02652-7. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39531096
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
Nakashima K, Yokomizo A, Murakami M, Okita K, Wada M, Iino K, Akechi T, Iihara H, Imamura CK, Okuyama A, Ozawa K, Kim YI, Sasaki H, Satomi E, Takeda M, Tanaka R, Nakajima TE, Nakamura N, Nishimura J, Noda M, Hayashi K, Higashi T, Boku N, Matsumoto K, Matsumoto Y, Yamamoto N, Aogi K, Abe M. Nakashima K, et al. Among authors: ozawa k. Int J Clin Oncol. 2024 Dec;29(12):1785-1794. doi: 10.1007/s10147-024-02643-8. Epub 2024 Oct 17. Int J Clin Oncol. 2024. PMID: 39417943
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.
Yokomizo A, Nakashima K, Iba A, Okita K, Wada M, Iino K, Akechi T, Iihara H, Imamura CK, Okuyama A, Ozawa K, Kim YI, Sasaki H, Satomi E, Takeda M, Tanaka R, Nakajima TE, Nakamura N, Nishimura J, Noda M, Hayashi K, Higashi T, Boku N, Matsumoto K, Matsumoto Y, Yamamoto N, Aogi K, Abe M. Yokomizo A, et al. Among authors: ozawa k. Int J Clin Oncol. 2024 Nov;29(11):1632-1640. doi: 10.1007/s10147-024-02624-x. Epub 2024 Sep 28. Int J Clin Oncol. 2024. PMID: 39340704
Severe Phenotype With RECQL4 Syndrome: A Report of Two Cases.
Kanai Y, Takahashi H, Hasegawa F, Mori A, Suzuki H, Takahashi S, Fukushima H, Takada H, Horie K, Ozawa K, Furukawa R, Kosaki K, Hata K. Kanai Y, et al. Among authors: ozawa k. Am J Med Genet A. 2024 Sep 26:e63884. doi: 10.1002/ajmg.a.63884. Online ahead of print. Am J Med Genet A. 2024. PMID: 39324487
2,074 results